|
|
Volumn 9, Issue 9, 1999, Pages 1249-1262
|
|
Developments in hepatitis C during 1997-1999
|
|
Author keywords
Antisense oligonucleotides; Helicase; Hepatitis C virus (HCV); Hypervariable region; Internal ribosomal entry site (IRES); Non structural genome; Nucleoside analogues; PEG IFN; Photopheresis; Protease; Ribozymes; RNA dependent RNA polymerase (rRDRP)
|
|
Indexed keywords
AMANTADINE;
AMPRENAVIR;
ANTIOXIDANT;
DNA VACCINE;
GUANIDINE;
HELICASE;
HEPATITIS VACCINE;
HERBACEOUS AGENT;
INTERFERON;
LAMIVUDINE;
METHOXSALEN;
MONOCLONAL ANTIBODY;
PEPTIDE;
PODOCARPIC ACID DERIVATIVE;
POLYCLONAL ANTIBODY;
PROTEINASE;
PROTEINASE INHIBITOR;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
RIBAVIRIN;
RIBOZYME;
SWAINSONINE;
THIOUREA;
UNINDEXED DRUG;
UREA;
VIRUS PROTEIN;
CHRONIC HEPATITIS;
DRUG DELIVERY SYSTEM;
HEPATITIS C;
HUMAN;
LIVER CELL CARCINOMA;
LIVER CIRRHOSIS;
ORAL DRUG ADMINISTRATION;
PATENT;
PREVALENCE;
PUVA;
REVIEW;
SIDE EFFECT;
SUBCUTANEOUS DRUG ADMINISTRATION;
SUBLINGUAL DRUG ADMINISTRATION;
VIRUS GENE;
|
|
EID: 0032850293
PISSN: 13543776
EISSN: None
Source Type: Journal
DOI: 10.1517/13543776.9.9.1249 Document Type: Review |
|
Times cited : (3)
|
|
References (182)
|
